Tapewire

Nasdaq · USD

CMPS

COMPASS Pathways plc

Export transactions ↓
Tapewire entity
4567
SEC CIK
0001816590
Parsed reports
137

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 03, 2026 Filed Aug 5, 2026 20:18 UTC
Nath KabirDirector · Chief Executive Officer
Tax withholdingOrdinary Shares 5,962 $11.25 $67,072.50
Disclosure

SEC source: 0001940258-26-000011 · wk-form4_1785961092.xml · nonDerivative · entry 1

Nath Kabir · CIK 0001940258 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 361,028

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · shares: Represents shares withheld by the Issuer upon vesting of restricted share units to satisfy tax withholding obligations.

Read SEC document
May 27, 2026 Filed May 29, 2026 21:16 UTC GrantShare Option (Right to Buy) · Derivative 21,110 $0.00 Strike: $11.85 $0.00
Disclosure

SEC source: 0001042021-26-000002 · wk-form4_1780089389.xml · derivative · entry 1

JONAS JEFFREY M · CIK 0001042021 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,110

Underlying: Ordinary Shares · 21,110 shares

Expires 2036-05-26

F1 · derivative.exercise_date: The shares underlying this option vest in full upon the earlier to occur of (i) the first anniversary of the date of grant or (ii) the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2027.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
May 27, 2026 Filed May 29, 2026 21:12 UTC GrantShare Option (Right to Buy) · Derivative 21,110 $0.00 Strike: $11.85 $0.00
Disclosure

SEC source: 0001898317-26-000002 · wk-form4_1780089156.xml · derivative · entry 1

McQuade Robert · CIK 0001898317 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,110

Underlying: Ordinary Shares · 21,110 shares

Expires 2036-05-26

F1 · derivative.exercise_date: The shares underlying this option vest in full upon the earlier to occur of (i) the first anniversary of the date of grant or (ii) the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2027.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
May 27, 2026 Filed May 29, 2026 21:31 UTC GrantShare Option (Right to Buy) · Derivative 21,110 $0.00 Strike: $11.85 $0.00
Disclosure

SEC source: 0001816952-26-000004 · wk-form4_1780090300.xml · derivative · entry 1

Karydas Daphne · CIK 0001816952 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,110

Underlying: Ordinary Shares · 21,110 shares

Expires 2036-05-26

F1 · derivative.exercise_date: The shares underlying this option vest in full upon the earlier to occur of (i) the first anniversary of the date of grant or (ii) the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2027.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
May 27, 2026 Filed May 29, 2026 21:26 UTC
SANTINI GINODirector
GrantShare Option (Right to Buy) · Derivative 30,158 $0.00 Strike: $11.85 $0.00
Disclosure

SEC source: 0001276038-26-000004 · wk-form4_1780090009.xml · derivative · entry 1

SANTINI GINO · CIK 0001276038 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,158

Underlying: Ordinary Shares · 30,158 shares

Expires 2036-05-26

F1 · derivative.exercise_date: The shares underlying this option vest in full upon the earlier to occur of (i) the first anniversary of the date of grant or (ii) the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2027.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
May 27, 2026 Filed May 29, 2026 21:17 UTC GrantShare Option (Right to Buy) · Derivative 21,110 $0.00 Strike: $11.85 $0.00
Disclosure

SEC source: 0001754129-26-000004 · wk-form4_1780089449.xml · derivative · entry 1

Gover Justin D. · CIK 0001754129 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,110

Underlying: Ordinary Shares · 21,110 shares

Expires 2036-05-26

F1 · derivative.exercise_date: The shares underlying this option vest in full upon the earlier to occur of (i) the first anniversary of the date of grant or (ii) the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2027.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
May 27, 2026 Filed May 29, 2026 21:13 UTC GrantShare Option (Right to Buy) · Derivative 21,110 $0.00 Strike: $11.85 $0.00
Disclosure

SEC source: 0001432895-26-000002 · wk-form4_1780089227.xml · derivative · entry 1

Riley Wayne Joseph · CIK 0001432895 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,110

Underlying: Ordinary Shares · 21,110 shares

Expires 2036-05-26

F1 · derivative.exercise_date: The shares underlying this option vest in full upon the earlier to occur of (i) the first anniversary of the date of grant or (ii) the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2027.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
May 27, 2026 Filed May 29, 2026 21:11 UTC GrantShare Option (Right to Buy) · Derivative 21,110 $0.00 Strike: $11.85 $0.00
Disclosure

SEC source: 0001529193-26-000002 · wk-form4_1780089107.xml · derivative · entry 1

Norton David Y · CIK 0001529193 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,110

Underlying: Ordinary Shares · 21,110 shares

Expires 2036-05-26

F1 · derivative.exercise_date: The shares underlying this option vest in full upon the earlier to occur of (i) the first anniversary of the date of grant or (ii) the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2027.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
May 27, 2026 Filed May 29, 2026 21:10 UTC GrantShare Option (Right to Buy) · Derivative 41,119 $0.00 Strike: $11.85 $0.00
Disclosure

SEC source: 0001830764-26-000004 · wk-form4_1780089046.xml · derivative · entry 1

Tregoning Kathleen · CIK 0001830764 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,119

Underlying: Ordinary Shares · 41,119 shares

Expires 2036-05-26

F1 · derivative.exercise_date: This option shall vest in 36 equal monthly installments over three years, with the first tranche vesting and becoming exercisable on June 27, 2026.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
March 26, 2026 Filed Mar 28, 2026 01:56 UTC
Nath KabirDirector · Chief Executive Officer
GrantShare Option (Right to Buy) · Derivative 367,815 $0.00 Strike: $5.64 $0.00
Disclosure

SEC source: 0001940258-26-000009 · wk-form4_1774662965.xml · derivative · entry 2

Nath Kabir · CIK 0001940258 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 367,815

Underlying: Ordinary Shares · 367,815 shares

Expires 2036-03-25

F3 · derivative.exercise_date: This Option shall vest in forty-eight equal monthly installments beginning on April 26, 2026.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
March 26, 2026 Filed Mar 28, 2026 01:56 UTC
Nath KabirDirector · Chief Executive Officer
GrantOrdinary Shares 175,000 $0.00 $0.00
Disclosure

SEC source: 0001940258-26-000009 · wk-form4_1774662965.xml · nonDerivative · entry 1

Nath Kabir · CIK 0001940258 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 366,990

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · shares: Represents an award of Restricted Share Units ("RSUs") granted under the Issuer's 2020 Share Option and Incentive Plan. Each RSU represents a contingent right to receive one Ordinary Share. The RSUs vest in four equal annual installments, with the first installment vesting on March 26, 2027.

F2 · acquired: Represents an award of Restricted Share Units ("RSUs") granted under the Issuer's 2020 Share Option and Incentive Plan. Each RSU represents a contingent right to receive one Ordinary Share. The RSUs vest in four equal annual installments, with the first installment vesting on March 26, 2027.

Read SEC document
March 26, 2026 Filed Mar 27, 2026 21:53 UTC
Goodwin GuyChief Medical Officer
GrantShare Option (Right to Buy) · Derivative 115,600 $0.00 Strike: $5.64 $0.00
Disclosure

SEC source: 0001898328-26-000002 · wk-form4_1774662783.xml · derivative · entry 2

Goodwin Guy · CIK 0001898328 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,600

Underlying: Ordinary Shares · 115,600 shares

Expires 2036-03-25

F3 · derivative.exercise_date: This Option shall vest in forty-eight equal monthly installments beginning on April 26, 2026.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
March 26, 2026 Filed Mar 27, 2026 21:53 UTC
Goodwin GuyChief Medical Officer
GrantShare Option (Right to Buy) · Derivative 55,000 $0.00 Strike: $0.01 $0.00
Disclosure

SEC source: 0001898328-26-000002 · wk-form4_1774662783.xml · derivative · entry 1

Goodwin Guy · CIK 0001898328 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Ordinary Shares · 55,000 shares

Expires 2036-03-25

F1 · derivative.exercise_date: The nominal cost share option shall vest in four equal annual installments beginning on March 26, 2027.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
March 26, 2026 Filed Mar 28, 2026 01:52 UTC
Loxam TeriChief Financial Officer
GrantShare Option (Right to Buy) · Derivative 157,635 $0.00 Strike: $5.64 $0.00
Disclosure

SEC source: 0001829111-26-000007 · wk-form4_1774662750.xml · derivative · entry 2

Loxam Teri · CIK 0001829111 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 157,635

Underlying: Ordinary Shares · 157,635 shares

Expires 2036-03-25

F3 · derivative.exercise_date: The share option shall vest in forty-eight equal monthly installments beginning on April 26, 2026.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
March 26, 2026 Filed Mar 28, 2026 01:52 UTC
Loxam TeriChief Financial Officer
GrantOrdinary Shares 75,000 $0.00 $0.00
Disclosure

SEC source: 0001829111-26-000007 · wk-form4_1774662750.xml · nonDerivative · entry 1

Loxam Teri · CIK 0001829111 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,002

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · shares: Represents an award of Restricted Share Units ("RSUs") granted under the Issuer's 2020 Share Option and Incentive Plan. Each RSU represents a contingent right to receive one Ordinary Share. The RSUs vest in four equal annual installments, with the first installment vesting on March 26, 2027.

Read SEC document
March 11, 2026 Filed Mar 13, 2026 21:04 UTC
Nath KabirDirector · Chief Executive Officer
Tax withholdingOrdinary Shares 13,131 $6.89 $90,472.59
Disclosure

SEC source: 0001940258-26-000006 · wk-form4_1773435891.xml · nonDerivative · entry 1

Nath Kabir · CIK 0001940258 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 191,990

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · shares: Represents shares withheld by the Issuer upon vesting of restricted share units to satisfy tax withholding obligations.

Read SEC document
March 11, 2026 Filed Mar 13, 2026 21:03 UTC
Loxam TeriChief Financial Officer
Tax withholdingOrdinary Shares 1,781 $6.89 $12,271.09
Disclosure

SEC source: 0001829111-26-000004 · wk-form4_1773435787.xml · nonDerivative · entry 1

Loxam Teri · CIK 0001829111 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,002

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · shares: Represents shares withheld by the Issuer upon vesting of restricted share units to satisfy tax withholding obligations.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 00:58 UTC
Loxam TeriChief Financial Officer
Tax withholdingOrdinary Shares 4,467 $7.02 $31,358.34
Disclosure

SEC source: 0001829111-26-000002 · wk-form4_1772585901.xml · nonDerivative · entry 1

Loxam Teri · CIK 0001829111 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,783

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · shares: Represents shares withheld by the Issuer upon vesting of restricted share units to satisfy tax withholding obligations.

Read SEC document
February 02, 2026 Filed Feb 3, 2026 22:19 UTC
Nath KabirDirector · Chief Executive Officer
Tax withholdingOrdinary Shares 16,181 $6.61 $106,956.41
Disclosure

SEC source: 0001940258-26-000004 · wk-form4_1770157192.xml · nonDerivative · entry 1

Nath Kabir · CIK 0001940258 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 205,121

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · balance_after: Represents shares withheld by the Issuer upon vesting of restricted share units to satisfy tax withholding obligations.

Read SEC document
October 29, 2025 Filed Oct 31, 2025 22:57 UTC GrantShare Option (Right to Buy) · Derivative 52,000 $0.00 Strike: $6.33 $0.00
Disclosure

SEC source: 0001042021-25-000005 · wk-form4_1761951440.xml · derivative · entry 1

JONAS JEFFREY M · CIK 0001042021 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,000

Underlying: Ordinary Shares · 52,000 shares

Expires 2035-10-28

F1 · derivative.exercise_date: This option shall vest in 36 equal monthly installments over three years, with the first tranche vesting and becoming exercisable on November 29, 2025.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
August 01, 2025 Filed Aug 5, 2025 01:31 UTC
Nath KabirDirector · Chief Executive Officer
Tax withholdingOrdinary Shares 6,366 $4.34 $27,628.44
Disclosure

SEC source: 0001816590-25-000106 · wk-form4_1754357466.xml · nonDerivative · entry 1

Nath Kabir · CIK 0001940258 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 221,302

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · balance_after: Represents shares withheld by the Issuer upon vesting of restricted share units to satisfy tax withholding obligations.

Read SEC document
July 29, 2025 Filed Jul 30, 2025 20:25 UTC GrantShare Option (Right to Buy) · Derivative 52,000 $0.00 Strike: $4.29 $0.00
Disclosure

SEC source: 0001816590-25-000099 · wk-form4_1753907148.xml · derivative · entry 1

Gover Justin D. · CIK 0001754129 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,000

Underlying: Ordinary Shares · 52,000 shares

Expires 2035-07-28

F1 · derivative.exercise_date: This option shall vest in 36 equal monthly installments over three years, with the first tranche vesting and becoming exercisable on August 29, 2025.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
June 12, 2025 Filed Jun 13, 2025 08:20 UTC GrantShare Option (Right to Buy) · Derivative 26,000 $0.00 Strike: $4.52 $0.00
Disclosure

SEC source: 0001816590-25-000073 · wk-form4_1749817239.xml · derivative · entry 1

Lonngren Thomas · CIK 0001898346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,000

Underlying: Ordinary Shares · 26,000 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The shares underlying this option vest in full upon the earlier to occur of (i) the first anniversary of the date of grant or (ii) the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2026.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
June 12, 2025 Filed Jun 13, 2025 12:24 UTC GrantShare Option (Right to Buy) · Derivative 26,000 $0.00 Strike: $4.52 $0.00
Disclosure

SEC source: 0001816590-25-000077 · wk-form4_1749817452.xml · derivative · entry 1

McQuade Robert · CIK 0001898317 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,000

Underlying: Ordinary Shares · 26,000 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The shares underlying this option vest in full upon the earlier to occur of (i) the first anniversary of the date of grant or (ii) the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2026.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
June 12, 2025 Filed Jun 13, 2025 12:18 UTC GrantShare Option (Right to Buy) · Derivative 26,000 $0.00 Strike: $4.52 $0.00
Disclosure

SEC source: 0001816590-25-000071 · wk-form4_1749817118.xml · derivative · entry 1

Karydas Daphne · CIK 0001816952 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,000

Underlying: Ordinary Shares · 26,000 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The shares underlying this option vest in full upon the earlier to occur of (i) the first anniversary of the date of grant or (ii) the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2026.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
June 12, 2025 Filed Jun 13, 2025 12:27 UTC GrantShare Option (Right to Buy) · Derivative 26,000 $0.00 Strike: $4.52 $0.00
Disclosure

SEC source: 0001816590-25-000081 · wk-form4_1749817660.xml · derivative · entry 1

Riley Wayne Joseph · CIK 0001432895 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,000

Underlying: Ordinary Shares · 26,000 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The shares underlying this option vest in full upon the earlier to occur of (i) the first anniversary of the date of grant or (ii) the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2026.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
June 12, 2025 Filed Jun 13, 2025 12:29 UTC
SANTINI GINODirector
GrantShare Option (Right to Buy) · Derivative 39,000 $0.00 Strike: $4.52 $0.00
Disclosure

SEC source: 0001816590-25-000083 · wk-form4_1749817775.xml · derivative · entry 1

SANTINI GINO · CIK 0001276038 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,000

Underlying: Ordinary Shares · 39,000 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The shares underlying this option vest in full upon the earlier to occur of (i) the first anniversary of the date of grant or (ii) the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2026.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
June 12, 2025 Filed Jun 13, 2025 12:22 UTC GrantShare Option (Right to Buy) · Derivative 26,000 $0.00 Strike: $4.52 $0.00
Disclosure

SEC source: 0001816590-25-000075 · wk-form4_1749817345.xml · derivative · entry 1

McGoldrick Linda · CIK 0001292629 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,000

Underlying: Ordinary Shares · 26,000 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The shares underlying this option vest in full upon the earlier to occur of (i) the first anniversary of the date of grant or (ii) the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2026.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
June 12, 2025 Filed Jun 13, 2025 12:26 UTC GrantShare Option (Right to Buy) · Derivative 26,000 $0.00 Strike: $4.52 $0.00
Disclosure

SEC source: 0001816590-25-000079 · wk-form4_1749817570.xml · derivative · entry 1

Norton David Y · CIK 0001529193 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,000

Underlying: Ordinary Shares · 26,000 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The shares underlying this option vest in full upon the earlier to occur of (i) the first anniversary of the date of grant or (ii) the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2026.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
June 12, 2025 Filed Jun 13, 2025 12:16 UTC GrantShare Option (Right to Buy) · Derivative 26,000 $0.00 Strike: $4.52 $0.00
Disclosure

SEC source: 0001816590-25-000069 · wk-form4_1749816998.xml · derivative · entry 1

Jenkins Annalisa · CIK 0001639481 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,000

Underlying: Ordinary Shares · 26,000 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The shares underlying this option vest in full upon the earlier to occur of (i) the first anniversary of the date of grant or (ii) the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2026.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
March 11, 2025 Filed Mar 13, 2025 12:14 UTC
Nath KabirDirector · Chief Executive Officer
GrantShare Option (Right to Buy) · Derivative 275,000 $0.00 Strike: $3.60 $0.00
Disclosure

SEC source: 0001816590-25-000024 · wk-form4_1741868088.xml · derivative · entry 2

Nath Kabir · CIK 0001940258 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 275,000

Underlying: Ordinary Shares · 275,000 shares

Expires 2035-03-10

F3 · derivative.exercise_date: This Option shall vest in forty-eight equal monthly installments beginning on April 11, 2025.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
March 11, 2025 Filed Mar 13, 2025 12:14 UTC
Nath KabirDirector · Chief Executive Officer
GrantOrdinary Shares 92,000 $0.00 $0.00
Disclosure

SEC source: 0001816590-25-000024 · wk-form4_1741868088.xml · nonDerivative · entry 1

Nath Kabir · CIK 0001940258 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 227,668

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · shares: Represents an award of Restricted Share Units ("RSUs") granted under the Issuer's 2020 Share Option and Incentive Plan. Each RSU represents a contingent right to receive one Ordinary Share. The RSUs vest in four equal annual installments, with the first installment vesting on March 11, 2026.

F2 · price: Represents an award of Restricted Share Units ("RSUs") granted under the Issuer's 2020 Share Option and Incentive Plan. Each RSU represents a contingent right to receive one Ordinary Share. The RSUs vest in four equal annual installments, with the first installment vesting on March 11, 2026.

Read SEC document
March 11, 2025 Filed Mar 13, 2025 08:15 UTC
Goodwin GuyChief Medical Officer
GrantShare Option (Right to Buy) · Derivative 63,000 $0.00 Strike: $3.60 $0.00
Disclosure

SEC source: 0001816590-25-000026 · wk-form4_1741868151.xml · derivative · entry 2

Goodwin Guy · CIK 0001898328 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,000

Underlying: Ordinary Shares · 63,000 shares

Expires 2035-03-10

F3 · derivative.exercise_date: This Option shall vest in forty-eight equal monthly installments beginning on April 11, 2025.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
March 11, 2025 Filed Mar 13, 2025 08:15 UTC
Goodwin GuyChief Medical Officer
GrantShare Option (Right to Buy) · Derivative 32,000 $0.00 Strike: $0.01 $0.00
Disclosure

SEC source: 0001816590-25-000026 · wk-form4_1741868151.xml · derivative · entry 1

Goodwin Guy · CIK 0001898328 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,000

Underlying: Ordinary Shares · 32,000 shares

Expires 2035-03-10

F1 · derivative.exercise_date: The nominal cost share option shall vest in four equal annual installments beginning on March 11, 2026.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
March 11, 2025 Filed Mar 13, 2025 12:15 UTC
Loxam TeriChief Financial Officer
GrantShare Option (Right to Buy) · Derivative 76,000 $0.00 Strike: $3.60 $0.00
Disclosure

SEC source: 0001816590-25-000025 · wk-form4_1741868121.xml · derivative · entry 2

Loxam Teri · CIK 0001829111 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,000

Underlying: Ordinary Shares · 76,000 shares

Expires 2035-03-10

F3 · derivative.exercise_date: The share option shall vest in forty-eight equal monthly installments beginning on April 11, 2025.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
March 11, 2025 Filed Mar 13, 2025 12:15 UTC
Loxam TeriChief Financial Officer
GrantOrdinary Shares 25,000 $0.00 $0.00
Disclosure

SEC source: 0001816590-25-000025 · wk-form4_1741868121.xml · nonDerivative · entry 1

Loxam Teri · CIK 0001829111 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,250

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · shares: Represents an award of Restricted Share Units ("RSUs") granted under the Issuer's 2020 Share Option and Incentive Plan. Each RSU represents a contingent right to receive one Ordinary Share. The RSUs vest in four equal annual installments, with the first installment vesting on March 11, 2026.

F2 · price: Represents an award of Restricted Share Units ("RSUs") granted under the Issuer's 2020 Share Option and Incentive Plan. Each RSU represents a contingent right to receive one Ordinary Share. The RSUs vest in four equal annual installments, with the first installment vesting on March 11, 2026.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 22:54 UTC
Loxam TeriChief Financial Officer
Tax withholdingOrdinary Shares 4,468 $3.67 $16,397.56
Disclosure

SEC source: 0001816590-25-000020 · wk-form4_1741128876.xml · nonDerivative · entry 1

Loxam Teri · CIK 0001829111 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,250

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · shares: Represents shares withheld by the Issuer upon vesting of restricted share units to satisfy tax withholding obligations.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 23:16 UTC
Nath KabirDirector · Chief Executive Officer
Tax withholdingOrdinary Shares 15,516 $4.31 $66,873.96
Disclosure

SEC source: 0001816590-25-000010 · wk-form4_1738797383.xml · nonDerivative · entry 1

Nath Kabir · CIK 0001940258 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,668

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · shares: Represents shares withheld by the Issuer upon vesting of restricted share units to satisfy tax withholding obligations.

Read SEC document
October 24, 2024 Filed Oct 25, 2024 08:27 UTC SaleOrdinary Shares 776,565 Not disclosed Not disclosed
Disclosure

SEC source: 0001816590-24-000126 · wk-form4_1729859226.xml · nonDerivative · entry 2

Malievskaia Ekaterina · CIK 0001898326 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By: Spouse

Disclosed balance after: 3,155,122

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · kind: The transaction is a private sale of American Depositary Shares (ADSs) to Lars Wilde, a former co-founder of Compass Pathways plc (the "Company"), pursuant to the terms of previously disclosed call option agreements dated May 19, 2020, as amended and restated on July 21, 2020, as further amended and restated on September 9, 2020, and as further amended effective February 15, 2023 by and among the Company and Mr. Wilde and each of Mr. Goldsmith and Dr. Malievskaia. Pursuant to the terms of such agreements, Mr. Wilde had an option to purchase 776,565 of ADSs for the nominal value per ordinary share, from each of Mr. Goldsmith and Dr. Malievskaia, exercisable at any time following our initial public offering until September 9, 2033. On October 24, 2024, Mr. Wilde delivered irrevocable exercise notices to purchase 776,565 from each of Mr. Goldsmith and Dr. Malievskaia.

F2 · price: The transaction is a private sale of American Depositary Shares (ADSs) to Lars Wilde, a former co-founder of Compass Pathways plc (the "Company"), pursuant to the terms of previously disclosed call option agreements dated May 19, 2020, as amended and restated on July 21, 2020, as further amended and restated on September 9, 2020, and as further amended effective February 15, 2023 by and among the Company and Mr. Wilde and each of Mr. Goldsmith and Dr. Malievskaia. Pursuant to the terms of such agreements, Mr. Wilde had an option to purchase 776,565 of ADSs for the nominal value per ordinary share, from each of Mr. Goldsmith and Dr. Malievskaia, exercisable at any time following our initial public offering until September 9, 2033. On October 24, 2024, Mr. Wilde delivered irrevocable exercise notices to purchase 776,565 from each of Mr. Goldsmith and Dr. Malievskaia.

F3 · ownership.nature: Securities held by George Jay Goldsmith, the Reporting Person's spouse. Dr. Malievskaia and Mr. Goldsmith are married but they expressly disclaim beneficial ownership of each other's shares in the Issuer.

Read SEC document
October 24, 2024 Filed Oct 25, 2024 08:27 UTC SaleOrdinary Shares 776,565 Not disclosed Not disclosed
Disclosure

SEC source: 0001816590-24-000126 · wk-form4_1729859226.xml · nonDerivative · entry 1

Malievskaia Ekaterina · CIK 0001898326 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,152,848

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · kind: The transaction is a private sale of American Depositary Shares (ADSs) to Lars Wilde, a former co-founder of Compass Pathways plc (the "Company"), pursuant to the terms of previously disclosed call option agreements dated May 19, 2020, as amended and restated on July 21, 2020, as further amended and restated on September 9, 2020, and as further amended effective February 15, 2023 by and among the Company and Mr. Wilde and each of Mr. Goldsmith and Dr. Malievskaia. Pursuant to the terms of such agreements, Mr. Wilde had an option to purchase 776,565 of ADSs for the nominal value per ordinary share, from each of Mr. Goldsmith and Dr. Malievskaia, exercisable at any time following our initial public offering until September 9, 2033. On October 24, 2024, Mr. Wilde delivered irrevocable exercise notices to purchase 776,565 from each of Mr. Goldsmith and Dr. Malievskaia.

F2 · price: The transaction is a private sale of American Depositary Shares (ADSs) to Lars Wilde, a former co-founder of Compass Pathways plc (the "Company"), pursuant to the terms of previously disclosed call option agreements dated May 19, 2020, as amended and restated on July 21, 2020, as further amended and restated on September 9, 2020, and as further amended effective February 15, 2023 by and among the Company and Mr. Wilde and each of Mr. Goldsmith and Dr. Malievskaia. Pursuant to the terms of such agreements, Mr. Wilde had an option to purchase 776,565 of ADSs for the nominal value per ordinary share, from each of Mr. Goldsmith and Dr. Malievskaia, exercisable at any time following our initial public offering until September 9, 2033. On October 24, 2024, Mr. Wilde delivered irrevocable exercise notices to purchase 776,565 from each of Mr. Goldsmith and Dr. Malievskaia.

Read SEC document
October 24, 2024 Filed Oct 25, 2024 12:25 UTC SaleOrdinary Shares 776,565 Not disclosed Not disclosed
Disclosure

SEC source: 0001816590-24-000125 · wk-form4_1729859113.xml · nonDerivative · entry 2

Goldsmith George Jay · CIK 0001843859 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By: Spouse

Disclosed balance after: 3,152,848

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · kind: The transaction is a private sale of American Depositary Shares (ADSs) to Lars Wilde, a former co-founder of Compass Pathways plc (the "Company"), pursuant to the terms of previously disclosed call option agreements dated May 19, 2020, as amended and restated on July 21, 2020, as further amended and restated on September 9, 2020, and as further amended effective February 15, 2023 by and among the Company and Mr. Wilde and each of Mr. Goldsmith and Dr. Malievskaia. Pursuant to the terms of such agreements, Mr. Wilde had an option to purchase 776,565 of ADSs for the nominal value per ordinary share, from each of Mr. Goldsmith and Dr. Malievskaia, exercisable at any time following our initial public offering until September 9, 2033. On October 24, 2024, Mr. Wilde delivered irrevocable exercise notices to purchase 776,565 from each of Mr. Goldsmith and Dr. Malievskaia.

F2 · price: The transaction is a private sale of American Depositary Shares (ADSs) to Lars Wilde, a former co-founder of Compass Pathways plc (the "Company"), pursuant to the terms of previously disclosed call option agreements dated May 19, 2020, as amended and restated on July 21, 2020, as further amended and restated on September 9, 2020, and as further amended effective February 15, 2023 by and among the Company and Mr. Wilde and each of Mr. Goldsmith and Dr. Malievskaia. Pursuant to the terms of such agreements, Mr. Wilde had an option to purchase 776,565 of ADSs for the nominal value per ordinary share, from each of Mr. Goldsmith and Dr. Malievskaia, exercisable at any time following our initial public offering until September 9, 2033. On October 24, 2024, Mr. Wilde delivered irrevocable exercise notices to purchase 776,565 from each of Mr. Goldsmith and Dr. Malievskaia.

F3 · ownership.nature: Securities held by Dr. Ekaterina Malievskaia, the Reporting Person's spouse. Dr. Malievskaia and Mr. Goldsmith are married but they expressly disclaim beneficial ownership of each other's shares in the Issuer.

Read SEC document
October 24, 2024 Filed Oct 25, 2024 12:25 UTC SaleOrdinary Shares 776,565 Not disclosed Not disclosed
Disclosure

SEC source: 0001816590-24-000125 · wk-form4_1729859113.xml · nonDerivative · entry 1

Goldsmith George Jay · CIK 0001843859 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,155,122

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · kind: The transaction is a private sale of American Depositary Shares (ADSs) to Lars Wilde, a former co-founder of Compass Pathways plc (the "Company"), pursuant to the terms of previously disclosed call option agreements dated May 19, 2020, as amended and restated on July 21, 2020, as further amended and restated on September 9, 2020, and as further amended effective February 15, 2023 by and among the Company and Mr. Wilde and each of Mr. Goldsmith and Dr. Malievskaia. Pursuant to the terms of such agreements, Mr. Wilde had an option to purchase 776,565 of ADSs for the nominal value per ordinary share, from each of Mr. Goldsmith and Dr. Malievskaia, exercisable at any time following our initial public offering until September 9, 2033. On October 24, 2024, Mr. Wilde delivered irrevocable exercise notices to purchase 776,565 from each of Mr. Goldsmith and Dr. Malievskaia.

F2 · price: The transaction is a private sale of American Depositary Shares (ADSs) to Lars Wilde, a former co-founder of Compass Pathways plc (the "Company"), pursuant to the terms of previously disclosed call option agreements dated May 19, 2020, as amended and restated on July 21, 2020, as further amended and restated on September 9, 2020, and as further amended effective February 15, 2023 by and among the Company and Mr. Wilde and each of Mr. Goldsmith and Dr. Malievskaia. Pursuant to the terms of such agreements, Mr. Wilde had an option to purchase 776,565 of ADSs for the nominal value per ordinary share, from each of Mr. Goldsmith and Dr. Malievskaia, exercisable at any time following our initial public offering until September 9, 2033. On October 24, 2024, Mr. Wilde delivered irrevocable exercise notices to purchase 776,565 from each of Mr. Goldsmith and Dr. Malievskaia.

Read SEC document
September 26, 2024 Filed Sep 28, 2024 00:00 UTC SaleOrdinary Shares 2,660,000 $6.05 $16,093,000.00
Disclosure

SEC source: 0001140361-24-042246 · form4.xml · nonDerivative · entry 1

ATAI Life Sciences N.V. · CIK 0001840904 · 10% owner

ATAI Life Sciences AG · CIK 0001776242 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By ATAI Life Sciences AG

Disclosed balance after: 6,905,774

F1 · ownership.nature: Securities held of record by ATAI Life Sciences AG, which is a wholly owned subsidiary of ATAI Life Sciences N.V., and as a result, ATAI Life Sciences N.V. may be deemed to share beneficial ownership over the Ordinary Shares held of record by ATAI Life Sciences AG.

Read SEC document
September 03, 2024 Filed Sep 4, 2024 23:42 UTC
SANTINI GINODirector
GrantShare Option (Right to Buy) · Derivative 52,000 $0.00 Strike: $7.22 $0.00
Disclosure

SEC source: 0001628280-24-039398 · wk-form4_1725487045.xml · derivative · entry 1

SANTINI GINO · CIK 0001276038 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,000

Underlying: Ordinary Shares · 52,000 shares

Expires 2034-09-02

F1 · derivative.exercise_date: This option shall vest in 36 equal monthly installments over three years, with the first tranche vesting and becoming exercisable on October 3, 2024.

F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 12:26 UTC
Nath KabirDirector · Chief Executive Officer
Tax withholdingOrdinary Shares 7,064 $6.88 $48,600.32
Disclosure

SEC source: 0001628280-24-034537 · wk-form4_1722860779.xml · nonDerivative · entry 1

Nath Kabir · CIK 0001940258 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 151,184

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · shares: Represents shares withheld by the Issuer upon vesting of restricted share units to satisfy tax withholding obligations.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 12:28 UTC Tax withholdingOrdinary Shares 161 $6.88 $1,107.68
Disclosure

SEC source: 0001628280-24-034539 · wk-form4_1722860886.xml · nonDerivative · entry 1

Jenkins Annalisa · CIK 0001639481 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,480

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · balance_after: Represents shares withheld by the Issuer upon vesting of restricted share units to satisfy tax withholding obligations.

Read SEC document
May 21, 2024 Filed May 22, 2024 16:22 UTC SaleOrdinary Shares 8,900 $7.91 $70,379.42
Disclosure

SEC source: 0001816590-24-000104 · wk-form4_1716409309.xml · nonDerivative · entry 4

Malievskaia Ekaterina · CIK 0001898326 · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By: Spouse

Disclosed balance after: 3,931,687

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F4 · shares: The reported sales occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by Mr. Goldsmith on August 23, 2023.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.83 to $8.03, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

F5 · ownership.nature: Securities held by George Jay Goldsmith, the Reporting Person's spouse. Dr. Malievskaia and Mr. Goldsmith are married but they expressly disclaim beneficial ownership of each other's shares in the Issuer.

Read SEC document
May 21, 2024 Filed May 22, 2024 16:22 UTC SaleOrdinary Shares 8,900 $7.91 $70,379.42
Disclosure

SEC source: 0001816590-24-000104 · wk-form4_1716409309.xml · nonDerivative · entry 3

Malievskaia Ekaterina · CIK 0001898326 · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,929,413

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · shares: The reported sales occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by Dr. Malievskaia on August 23, 2023.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.83 to $8.03, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

Read SEC document
May 21, 2024 Filed May 22, 2024 20:21 UTC SaleOrdinary Shares 8,900 $7.91 $70,379.42
Disclosure

SEC source: 0001816590-24-000103 · wk-form4_1716409264.xml · nonDerivative · entry 4

Goldsmith George Jay · CIK 0001843859 · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By: Spouse

Disclosed balance after: 3,929,413

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F4 · shares: The reported sales occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by Dr. Malievskaia on August 23, 2023.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.83 to $8.03, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

F5 · ownership.nature: Securities held by Dr. Ekaterina Malievskaia, the Reporting Person's spouse. Dr. Malievskaia and Mr. Goldsmith are married but they expressly disclaim beneficial ownership of each other's shares in the Issuer.

Read SEC document
May 21, 2024 Filed May 22, 2024 20:21 UTC SaleOrdinary Shares 8,900 $7.91 $70,379.42
Disclosure

SEC source: 0001816590-24-000103 · wk-form4_1716409264.xml · nonDerivative · entry 3

Goldsmith George Jay · CIK 0001843859 · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,931,687

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · shares: The reported sales occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by Mr. Goldsmith on August 23, 2023.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.83 to $8.03, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.